Marker Therapeutics Correlations

MRKR Stock

USD 3.26 0.07 2.10%

The current 90-days correlation between Marker Therapeutics and Lumos Pharma is 0.2 (i.e., Modest diversification). The correlation of Marker Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Marker Therapeutics Correlation With Market

Modest diversification

The correlation between Marker Therapeutics and DJI is 0.26 (i.e., Modest diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Marker Therapeutics and DJI in the same portfolio, assuming nothing else is changed.

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Marker Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in industry.

To learn how to invest in Marker Stock, please use our How to Invest in Marker Therapeutics guide.

Moving together with Marker Stock

0.7	LPTX	Leap Therapeutics	Pair Corr
0.83	PLRX	Pliant Therapeutics	Pair Corr
0.79	PMVP	Pmv Pharmaceuticals	Pair Corr

Moving against Marker Stock

0.5	MNOV	MediciNova	Pair Corr
0.45	MRK	Merck Company Fiscal Year End 6th of February 2025	Pair Corr
0.39	FDMT	4D Molecular Therapeutics	Pair Corr
0.35	NKTX	Nkarta Inc Buyout Trend	Pair Corr
0.59	ACIU	AC Immune	Pair Corr
0.35	COLL	Collegium Pharmaceutical	Pair Corr
0.33	BDTX	Black Diamond Therap	Pair Corr
0.31	SYBX	Synlogic	Pair Corr

Related Correlations Analysis

	LUMO	XCUR	PTIX	PMVP	ANEB	MIRO	ZIVO	BNOX	AGEN	ICVX
LUMO		0.31	-0.2	0.78	-0.51	0.86	-0.74	-0.5	-0.69	0.37	LUMO
XCUR	0.31		-0.01	0.1	-0.44	0.27	-0.6	-0.24	-0.41	0.15	XCUR
PTIX	-0.2	-0.01		0.0	-0.06	-0.04	0.02	0.31	0.2	-0.34	PTIX
PMVP	0.78	0.1	0.0		-0.48	0.8	-0.59	-0.39	-0.57	0.23	PMVP
ANEB	-0.51	-0.44	-0.06	-0.48		-0.58	0.71	0.44	0.69	-0.2	ANEB
MIRO	0.86	0.27	-0.04	0.8	-0.58		-0.8	-0.53	-0.75	0.33	MIRO
ZIVO	-0.74	-0.6	0.02	-0.59	0.71	-0.8		0.65	0.88	-0.44	ZIVO
BNOX	-0.5	-0.24	0.31	-0.39	0.44	-0.53	0.65		0.7	-0.85	BNOX
AGEN	-0.69	-0.41	0.2	-0.57	0.69	-0.75	0.88	0.7		-0.53	AGEN
ICVX	0.37	0.15	-0.34	0.23	-0.2	0.33	-0.44	-0.85	-0.53		ICVX
	LUMO	XCUR	PTIX	PMVP	ANEB	MIRO	ZIVO	BNOX	AGEN	ICVX

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

AGEN	+ 0.88	ZIVO
MIRO	+ 0.86	LUMO
MIRO	+ 0.8	PMVP
PMVP	+ 0.78	LUMO
ZIVO	+ 0.71	ANEB
AGEN	+ 0.7	BNOX

High negative correlations

ICVX	- 0.85	BNOX
ZIVO	- 0.8	MIRO
AGEN	- 0.75	MIRO
ZIVO	- 0.74	LUMO
AGEN	- 0.69	LUMO
ZIVO	- 0.6	XCUR

Risk-Adjusted Indicators

There is a big difference between Marker Stock performing well and Marker Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Marker Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
LUMO	2.36	0.30	0.03	(0.32)	2.94	(2.59)	5.95	(5.19)	16.25
XCUR	13.67	5.35	0.70	1.53	6.45	(19.92)	47.72	(12.92)	95.22
PTIX	6.36	0.76	0.05	(0.36)	7.09	(7.35)	18.33	(12.07)	47.50
PMVP	1.61	0.03	(0.03)	0.25	2.00	(1.97)	3.75	(3.64)	13.98
ANEB	5.13	(0.11)	0.00	0.21	0.00	0.00	8.61	(11.48)	76.00
MIRO	4.85	0.53	0.05	(0.52)	5.26	(6.37)	11.73	(8.87)	38.49
ZIVO	3.01	(0.55)	0.00	0.81	0.00	0.00	5.31	(6.67)	36.36
BNOX	9.07	0.13	0.01	0.21	11.15	(16.06)	11.86	(24.00)	200.75
AGEN	3.77	(1.09)	0.00	(0.22)	0.00	0.00	6.59	(8.60)	27.05
ICVX	4.87	1.33	0.17	(0.37)	4.56	(5.67)	10.22	(6.79)	38.57

Marker Therapeutics Corporate Management

Gerald Garrett	Senior Operations	Profile
Juan MD	COO, CoFounder	Profile
Peter MBA	CEO Pres	Profile
Nadia Agopyan	Senior Affairs	Profile
Monic MD	Chief Officer	Profile
Michael Loiacono	Treasurer Secretary	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC